The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective review of outcomes of patients with multiple myeloma with COVID-19 infection (two-center study).
 
Hamid Ehsan
No Relationships to Disclose
 
Alec Britt
No Relationships to Disclose
 
Peter M. Voorhees
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Oncopeptides; Pfizer; Sanofi; Secura Bio
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Sanofi
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
Barry Paul
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Janssen Oncology
Speakers' Bureau - Amgen
 
Manisha Bhutani
Research Funding - Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); C4 Therapeutics (Inst); Celularity (Inst); Cerecor (Inst); Janssen Research & Development (Inst); MedImmune (Inst); Millenium Pharamceuticals (Inst)
 
Cindy Varga
Honoraria - Adaptive Biotechnologies
 
Zane Chiad
No Relationships to Disclose
 
Brittany K. Ragon
No Relationships to Disclose
 
Zainab Shahid
No Relationships to Disclose
 
Moussa Shahoud
No Relationships to Disclose
 
Al-Ola A. Abdallah
Research Funding - Abbvie (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Sanofi (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - PSA vaccine patent
 
Nausheen Ahmed
No Relationships to Disclose
 
Shebli Atrash
Honoraria - Janssen
Speakers' Bureau - Celgene; Janssen
Research Funding - Amgen; Celgene/Bristol-Myers Squibb (Inst); GlaxoSmithKline; Janssen Oncology (Inst); Karyopharm Therapeutics